Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cronos Group Inc T.CRON

Alternate Symbol(s):  CRON

Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and... see more

TSX:CRON - Post Discussion

Cronos Group Inc > Raymond James: Cronos Financials A “Relative Non-Event”
View:
Post by AwareInvestor on Mar 01, 2021 9:52am

Raymond James: Cronos Financials A “Relative Non-Event”

On February 26th, Cronos Group reported fourth quarter and full year financial results. The company reported fourth quarter total revenue of C$17 million, a 50% increase quarter over quarter, while also reporting negative gross margins of 87% or -C$14.9 million. Adjusted EBITDA came in at -C$53.1 million. For the full year, Cronos reported net revenues of $46.7 million, an almost 100% increase year over year; adjusted EBITDA came in at -C$147.3 million for the full year.
 
Cronos Group currently has 11 analysts covering the company with a weighted 12-month price target of C$9.69. This is slightly up from the average before the results, which was C$8.74. Two analysts have buy ratings, seven analysts have hold ratings, while two analysts have strong sells on the company.

https://thedeepdive.ca/raymond-james-cronos-financials-a-relative-non-event/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities